Continuus Pharmaceuticals, INC.

$74M obligated·2 awards·2 agencies·2 NAICS

Federal Contracts

Showing award actions 1–3 of 3 funded award actions, most recent first.

Contracts with positive obligations: 2
Funded award actions shown: 3
Obligations shown: $74M
Awarding agencies: 2

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of May 12, 2023. Source: USAspending federal award records.

Date	Agency	PIID	NAICS	Description	Amount
Jan 15, 2021	Department of DefenseFA8505 AFLCMC WAQKB	FA850521C0001	325412	COVID-19 DHHS CAPACITY EXPANSION TO PROVIDE INTEGRATED CONTINUOUS MANUFACTURING OF THREE COVID RELATED PHARMACEUTICALS. CONTRACT WILL RESULT IN CAPACITY TO PRODUCE 100M DOSES PER YEAR.	$69M
Sep 20, 2016	Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS	HHSF223201610104C	541712	IGF::CL::IGF BAA CONTRACT TITLED, "ADVANCEMENT OF INTEGRATED CONTINUOUS MANUFACTURING (ICM)UNIT OPERATIONS."	$180K
Sep 8, 2016	Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS	HHSF223201610104C	541712	IGF::CL::IGF BAA CONTRACT TITLED, "ADVANCEMENT OF INTEGRATED CONTINUOUS MANUFACTURING (ICM)UNIT OPERATIONS."	$4.2M

Get Alerted Before Continuus Pharmaceuticals, INC.'s Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free